Healthcare Triangle Enters Warrant Exercise Agreements for $1.63 Million

PLEASANTON, CA — October 2, 2025 — Leads & Copy — Healthcare Triangle, Inc. (Nasdaq: HCTI) has entered into warrant exercise agreements with three existing accredited investors to exercise outstanding warrants for 812,775 shares of common stock. The immediate exercise will yield gross cash proceeds of approximately $1.63 million. Exercising holders will receive new unregistered warrants to purchase up to 812,775 shares of common stock with an exercise price of $3.00 per share via private placement. The new warrants are initially exercisable upon stockholder approval and expire five years from approval date.

In connection with the warrant exercises the company reduced the existing warrant exercise price from $20.92 to $2.00 per share. The closing is expected to occur on or about October 2, 2025, contingent on customary conditions. WallachBeth Capital is the sole placement agent for the warrant inducement transaction.

Healthcare Triangle reinforces healthcare progress through technology and extensive industry knowledge. They support healthcare organizations in improving health outcomes through better utilization of data and information technologies. The company enables the adoption of new technologies, data enlightenment, business agility, and response to immediate business needs.

This announcement does not constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction where such offer, solicitation or sale would be unlawful.

Investors can contact Healthcare Triangle at 1-800-617-9550 or ir@healthcaretriangle.com.

Source: Healthcare Triangle, Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.